A step forward has been achieved in the pathway to establish optimal cancer screening for
myositis patients. International consensus guidelines for an effective diagnostic work-up of …

Inclusion body myositis (IBM) is an acquired, late-onset inflammatory myopathy, with both
inflammatory and degenerative pathogenesis. Although idiopathic inflammatory myopathies …

Valosin-containing protein (VCP) gene mutations have been associated with a rare
autosomal dominant, adult-onset progressive disease known as multisystem proteinopathy …

OBJECTIVES: Sporadic inclusion body myositis (IBM) is the most common acquired
myopathy in those aged above 50. It is classically heralded by weakness in the long finger …

Objective To show the predictive risk factors for aspiration pneumonia and prognostic
importance of a cricopharyngeal bar (CPB) on videofluoroscopic examination of swallowing …

Background Inclusion body myositis (IBM) is a unique idiopathic inflammatory myopathy with
unclear pathogenesis and poor prognosis. Although previous publications have identified …

Inclusion body myositis (IBM) is an inflammatory and degenerative skeletal muscle condition
of unknown etiology. Certain features suggest underlying autoimmunity, while other findings …

Inclusion body myositis is part of the group of inflammatory myopathies, representing 30% of
this group of diseases, and is considered an orphan disease because its estimated …

Inclusion body myositis is part of the group of inflammatory myopathies, representing 30% of
this group of diseases, and is considered an orphan disease because its estimated …

La miositis por cuerpos de inclusión forma parte del grupo de las miopatías inflamatorias, de
las que representa el 30%; es considerada una enfermedad huérfana, ya que se estima que …